Influência da naloxona e metisergida sobre o efeito analgésico do laser em baixa intensidade em modelo experimental de dor
Influence of naloxone and methysergide on the analgesic effects of low-level laser in an experimental pain model
André Peres e Serra; Hazem A Ashmawi
Resumo
Palavras-chave
Abstract
Keywords
References
Merskey H, Albe-Fessard DG, Bonica JJ. Pain terms: a list with definition and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979;6:249-252.
Hopkins JT, McLoda TA, Seegmiller JG. Low-level laser therapy facilitates superficial wound healing in humans: a triple-blind, sham-controlled study. J Athl Train. 2004;39:223-229.
Martin KR, Broadway DC. Cyclodiode laser therapy for painful, blind glaucomatous eyes. Br J Ophthalmol. 2001;85:474-476.
Brown GC, Brown MM, Sharma S. Cost-effectiveness of treatment for threshold retinopathy of prematurity. Pediatrics. 1999;104.
Trehan M, Taylor CR. Low-dose excimer 308-nm laser for the treatment of oral lichen planus. Arch Dermatol. 2004;140:415-420.
Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149-1155.
Schubert MM, Eduardo FP, Guthrie KA. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 2007;15:1145-1154.
Eduardo FP, Bezinelli LM, Luiz AC, Correa L, Vogel C, Eduardo CP. Severity of Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation and an Oral Laser Phototherapy Protocol: A Survey of 30 Patients. Photomed Laser Surg. 2008;26.
Fikácková H, Dostálová T, Navrátil L. Effectiveness of low-level laser therapy in temporomandibular joint disorders: a placebo-controlled study. Photomed Laser Surg. 2007;25:297-303.
Karu TI. Low-Power Laser Therapy. Biomedical Photonics Handbook. 2003.
Kujawa J, Zavodnik L, Zavodnik I. Effect of low-intensity (3. 75-25 J/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure. J Clin Laser Med Surg. 2004;22:111-117.
Yasukawa A, Hrui H, Koyama Y. The effect of low reactive-level laser therapy (LLLT) with helium-neon laser on operative wound healing in a rat model. J Vet Med Sci. 2007;69:799-806.
Karu TI, Pyatibrat LV, Afanasyeva NI. Cellular effects of low power laser therapy can be mediated by nitric oxide. Lasers Surg Med. 2005;36:307-314.
Albertini R, Aimbire FS, Correa FI. Effects of different protocol doses of low power gallium-aluminum-arsenate (Ga-Al-As) laser radiation (650 nm) on carrageenan induced rat paw oedema. J Photochem Photobiol B. 2004;74:101-107.
Vladimirov YA, Osipov AN, Klebanov GI. Photobiological principles of therapeutic applications of laser radiation. Biochemistry (Mosc). 2004;69:81-90.
Karu TI, Tiphlova O, Esenaliev R. Two different mechanisms of low-intensity laser photobiological effects on Escherichia coli. J Photochem Photobiol B. 1994;24:155-161.
Bertoloni G, Sacchetto R, Baro E. Biochemical and morphological changes in Escherichia coli irradiated by coherent and non-coherent 632. 8 nm light. J Photochem Photobiol B. 1993;18:191-196.
Honmura A, Ishii A, Yanase M. Analgesic effect of Ga-Al-As diode laser irradiation on hyperalgesia in carrageenin-induced inflammation. Lasers Surg Med. 1993;13:463-469.
Hagiwara S, Iwasaka H, Okuda K. GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med. 2007;39:797-802.
Ferreira DM, Zângaro RA, Villaverde AB. Analgesic effect of He-Ne (632. 8 nm) low-level laser therapy on acute inflammatory pain. Photomed Laser Surg. 2005;23:177-181.
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109-110.
Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544-547.
Laakso EL, Cabot PJ. Nociceptive scores and endorphin-containing cells reduced by low-level laser therapy (LLLT) in inflamed paws of Wistar rat. Photomed Laser Surg. 2005;23:32-35.
Ngai SH, Berkowitz BA, Yang JC. Pharmacokinetics of naloxone in rat and man: basis for its potency and short duration of action. Anesthesiology. 1976;44:398-401.
Kaufman RD, Gabathuler ML, Bellville JW. Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration. J Pharmacol Exp Ther. 1981;219:156-162.
Napimoga MH, Souza GR, Cunha TM. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J Pharmacol Exp Ther. 2008;324:313-321.
Gutierrez VP, Konno K, Chacur M. Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors. Eur J Pharmacol. 2008;594:84-92.
Abbott FV, Hong Y, Blier P. Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 1996;35:99-110.
Doak GJ, Sawynok J. Formalin induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxitryptamine receptor subtypes. Neuroscience. 1997;80:939-949.
Colpaert FC. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief. Curr Opin Investig Drugs. 2006;7:40-47.